Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 6/20 | 0.82 |
| ▸ | PPARD | Q03181 | 4/20 | 0.82 |
| ▸ | PPARA | Q07869 | 4/20 | 0.82 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.78 |
| ▸ | TRPM7 | Q96QT4 | 1/20 | 0.78 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.78 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.74 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.74 |
| ▸ | CRHBP | P24387 | 1/20 | 0.59 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.59 |
| ▸ | CNR2 | P34972 | 3/20 | 0.56 |
| ▸ | CNR1 | P21554 | 2/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | INHA | P05111 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29349841 | 1.00 | PPARG (0.82) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL25560675 | 0.93 | PPARG (0.78) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL25808457 | 0.91 | PPARG (0.67) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL23465691 | 0.91 | PPARG (0.67) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL2109843 | 0.91 | PPARG (1.00) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL19460455 | 0.89 | SLC6A3 (0.74) | PPARGPPARDPPARASLC6A3TRPM7 | |
| SCHEMBL25560799 | 0.89 | PPARG (0.78) | PPARGPPARDPPARASLC6A3TRPM7 | |
| Cannabigerolic Acid SCHEMBL29489281 | 0.88 | SLC6A3 (1.00) | PPARGPPARDPPARASLC6A3TRPM7 | |
| Cannabigerolic Acid SCHEMBL9909324 | 0.88 | SLC6A3 (1.00) | PPARGPPARDPPARASLC6A3TRPM7 | |
| Cannabigerolic Acid SCHEMBL29611010 | 0.88 | SLC6A3 (1.00) | PPARGPPARDPPARASLC6A3TRPM7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036258-B2 | Encapsulated cannabinoid comestible noble metal compositions and products, methods of preparing same | KIFFEN LLC (US) | 2024-07-16 | — | — | US | disclosed |
| US-12036258-B2 | Encapsulated cannabinoid comestible noble metal compositions and products, methods of preparing same | KIFFEN LLC (US) | 2024-07-16 | — | — | US | disclosed |
| US-20240026392-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2024-01-25 | — | — | US | disclosed |
| US-20240026392-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2024-01-25 | — | — | US | disclosed |
| US-20230381205-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURONAL DISORDERS WITH CANNABINOIDS | INMED PHARMACEUTICALS INC. (CA) | 2023-11-30 | — | — | US | disclosed |
| US-20230381205-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURONAL DISORDERS WITH CANNABINOIDS | INMED PHARMACEUTICALS INC. (CA) | 2023-11-30 | — | — | US | disclosed |
| WO-2023225403-A2 | CANNABINOID ACIDS CRYSTALLINE FORMS, METHODS OF PRODUCING, AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-11-23 | — | — | WO | disclosed |
| US-20230340446-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230340446-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230284578-A1 | EXTRACTS OF CBD AND THC | NEXUS AGRISCIENCE, INC. | 2023-09-14 | — | — | US | disclosed |
| US-20140271940-A1 | BIOACTIVE CONCENTRATES AND USES THEREOF | SC LABORATORIES, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140271940-A1 | BIOACTIVE CONCENTRATES AND USES THEREOF | SC LABORATORIES, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140065243-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | SUTTER WEST BAY HOSPITALS | 2014-03-06 | — | — | US | disclosed |
| US-20140065243-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | SUTTER WEST BAY HOSPITALS | 2014-03-06 | — | — | US | disclosed |
| US-8158681-B2 | Nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders | DSM IP ASSETS B.V. (NL) | 2012-04-17 | — | — | US | disclosed |
| US-20100204312-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | CALIFORNIA PACIFIC MEDICAL CENTER (US) | 2010-08-12 | — | — | US | disclosed |
| US-20100204312-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | CALIFORNIA PACIFIC MEDICAL CENTER (US) | 2010-08-12 | — | — | US | disclosed |
| US-20100055218-A1 | NOVEL COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2010-03-04 | — | — | US | disclosed |
| US-20100056463-A1 | NOVEL COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2010-03-04 | — | — | US | disclosed |
| US-20080319071-A1 | Novel Nutraceutical and Pharmaceutical Compositions and Use Thereof for the Treatment, Co-Treatment or Prevention of Inflammatory Disorders | DSM IP ASSETS B.V. (NL) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319071-A1 | Novel Nutraceutical and Pharmaceutical Compositions and Use Thereof for the Treatment, Co-Treatment or Prevention of Inflammatory Disorders | TNF, VDR, FABP6 | PPARG 7/4885PPARD 42/4885PPARA 30/4885 |
| US-20140065243-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | CNR2, CNR1, JUP | PPARG 124/4885PPARD 298/4885PPARA 217/4885 |
| US-20100204312-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | CNR2, CNR1, JUP | PPARG 124/4885PPARD 298/4885PPARA 217/4885 |
| US-20230381205-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURONAL DISORDERS WITH CANNABINOIDS | CNR2, CNR1, GAP43 | PPARG 1354/4885PPARD 2502/4885PPARA 2206/4885 |
| US-12036258-B2 | Encapsulated cannabinoid comestible noble metal compositions and products, methods of preparing same | CNR2, CNR1, NOTUM | PPARG 328/4885PPARD 415/4885PPARA 404/4885 |
| US-20140271940-A1 | BIOACTIVE CONCENTRATES AND USES THEREOF | CNR2, CNR1, CDIPT | PPARG 87/4885PPARD 113/4885PPARA 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.